MCP AbD Serotec
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 1, 2006.
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
T600025-MCP200v1
5/11/2175    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blanchard, D.
Right arrow Articles by Fire, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanchard, D.
Right arrow Articles by Fire, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on May 3, 2006
Revised on July 18, 2006
Accepted on August 15, 2006

A differential cytolocalization assay for analysis of macromolecular assemblies in the eukaryotic cytoplasm

Daniel Blanchard, Harald Hutter, Jamie Fleenor, and Andrew Fire

Pathology/Genetics, Stanford, Stanford, CA 94305-5324

Corresponding Author: afire{at}stanford.edu

We have developed a differential cytolocalization assay (DCLA) that allows the observation of cytoplasmic protein:protein interactions in vivo. In the DCLA assay, interactions are visualized as a relocalization of a GFP-tagged “prey” by a membrane bound “bait”. This assay has been tested and utilized in C. elegans to probe interactions among proteins involved in RNA interference (RNAi) and nonsense mediated decay (NMD) pathways. Several previously documented interactions have been confirmed with DCLA, while uniformly negative results were obtained in several controls in which no interaction was expected. Novel interactions were also observed including the association of SMG-5, a protein required for NMD, to several components of the RNAi pathway. The DCLA assay can be readily carried out under diverse conditions, allowing a dynamic assessment of protein interactions in vivo. We have used this property to test a subset of the RNAi and NMD interactions in animals mutant for proteins central to each mechanism, identifying several key associations in each machinery that can occur in vivo in the absence of a functional process.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.